HHS and the Federal Communications Commission have created a new advisory panel, the Food and Drug Administration Safety Innovation Act Workgroup, meant to promote patient safety and foster innovation associated with health information technology. The panel, which convenes next week, will also focus on ways to avoid regulatory duplication.

Related Summaries